Par Pharmaceutical Travoprost Ophthalmic Solution Recall: Risk of Contamination
Par Pharmaceutical recalls Travoprost Ophthalmic Solution 0.004% bottles due to lack of sterility assurance and potential dropper damage. This medication is for eye use only and requires immediate attention.
Recall notice
Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container
Contact the company
What happened, in plain English
Par Pharmaceutical is recalling Travoprost Ophthalmic Solution 0.004% eye drops in 2.5 mL and 5 mL bottles because they may not be sterile and could damage the dropper tip. This poses a risk of contamination and eye injury if used. Read more at govinfonow.com/recall/42300-par-pharmaceutical-travoprost-ophthalmic-solution-recall-risk-of-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/42300-par-pharmaceutical-travoprost-ophthalmic-solution-recall-risk-of-contamination · Updated October 9, 2026 · FDA enforcement record: FDA #D-0154-2017
Cite this page
“Par Pharmaceutical Travoprost Ophthalmic Solution Recall: Risk of Contamination.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42300-par-pharmaceutical-travoprost-ophthalmic-solution-recall-risk-of-contamination. Based on FDA recall #D-0154-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0154-2017%22&limit=1).
Why it’s dangerous
The medication may not be sterile, which could lead to infections or eye injuries. Damage to the dropper tip might cause the solution to leak or contaminate the eye.
Who’s affected
People prescribed this eye drop medication by a doctor are affected. Those with existing eye conditions may be at higher risk due to potential contamination.
How to tell if you have this one
Check for bottles labeled 'Travoprost Ophthalmic Solution USP 0.004%' with specific lot numbers like GA50089 or GA51761. These were made in India and distributed by Par Pharmaceutical.
- Brand
Par Pharmaceutical- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers listed in the recall notice to confirm if your bottle is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this medication safe to use?
The recall states there is a risk of contamination and dropper damage, so it is not safe to use without checking the recall status.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0154-2017 (October 5, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0154-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.